These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 15365614)

  • 1. Conformation-dependent GAD65 autoantibodies in diabetes.
    Luo D; Gilliam LK; Greenbaum C; Bekris L; Hampe CS; Daniels T; Richter W; Marcovina SM; Rolandsson O; Landin-Olsson M; Kockum I; Lernmark A
    Diabetologia; 2004 Sep; 47(9):1581-91. PubMed ID: 15365614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of glutamic acid decarboxylase autoantibody heterogeneity and epitope regions in type I diabetes.
    Ujihara N; Daw K; Gianani R; Boel E; Yu L; Powers AC
    Diabetes; 1994 Aug; 43(8):968-75. PubMed ID: 8039604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fusion proteins for combined analysis of autoantibodies to the 65-kDa isoform of glutamic acid decarboxylase and islet antigen-2 in insulin-dependent diabetes mellitus.
    Rickert M; Seissler J; Dangel W; Lorenz H; Richter W
    Clin Chem; 2001 May; 47(5):926-34. PubMed ID: 11325898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different GAD antibody-positive phenotypes.
    Hampe CS; Hammerle LP; Bekris L; Ortqvist E; Kockum I; Rolandsson O; Landin-Olsson M; Törn C; Persson B; Lernmark A
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4671-9. PubMed ID: 11134126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two amino acids in glutamic acid decarboxylase act in concert for maintenance of conformational determinants recognised by Type I diabetic autoantibodies.
    Tree TI; Morgenthaler NG; Duhindan N; Hicks KE; Madec AM; Scherbaum WA; Banga JP
    Diabetologia; 2000 Jul; 43(7):881-9. PubMed ID: 10952461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Species-specific autoantibodies in type 1 diabetes.
    Hampe CS; Ortqvist E; Rolandsson O; Landin-Olsson M; Törn C; Agren A; Persson B; Schranz DB; Lernmark A
    J Clin Endocrinol Metab; 1999 Feb; 84(2):643-8. PubMed ID: 10022431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of epitope recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different autoimmune disorders.
    Powers AC; Bavik K; Tremble J; Daw K; Scherbaum WA; Banga JP
    Clin Exp Immunol; 1999 Dec; 118(3):349-56. PubMed ID: 10594551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiplicity of the antibody response to GAD65 in Type I diabetes.
    Gilliam LK; Binder KA; Banga JP; Madec AM; Ortqvist E; Kockum I; Luo D; Hampe CS
    Clin Exp Immunol; 2004 Nov; 138(2):337-41. PubMed ID: 15498046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic sensitivity of immunodominant epitopes of glutamic acid decarboxylase (GAD65) autoantibodies in childhood IDDM.
    Falorni A; Ackefors M; Carlberg C; Daniels T; Persson B; Robertson J; Lernmark A
    Diabetologia; 1996 Sep; 39(9):1091-8. PubMed ID: 8877294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant Fabs of human monoclonal antibodies specific to the middle epitope of GAD65 inhibit type 1 diabetes-specific GAD65Abs.
    Padoa CJ; Banga JP; Madec AM; Ziegler M; Schlosser M; Ortqvist E; Kockum I; Palmer J; Rolandsson O; Binder KA; Foote J; Luo D; Hampe CS
    Diabetes; 2003 Nov; 52(11):2689-95. PubMed ID: 14578287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The PEVKEK region of the pyridoxal phosphate binding domain of GAD65 expresses a dominant B cell epitope for type 1 diabetes sera.
    Tong JC; Myers MA; Mackay IR; Zimmet PZ; Rowley MJ
    Ann N Y Acad Sci; 2002 Apr; 958():182-9. PubMed ID: 12021103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GAD65-specific autoantibodies enhance the presentation of an immunodominant T-cell epitope from GAD65.
    Reijonen H; Daniels TL; Lernmark A; Nepom GT
    Diabetes; 2000 Oct; 49(10):1621-6. PubMed ID: 11016444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Murine monoclonal glutamic acid decarboxylase (GAD)65 antibodies recognize autoimmune-associated GAD epitope regions targeted in patients with type 1 diabetes mellitus and stiff-man syndrome.
    Ziegler B; Schlosser M; Lühder F; Strebelow M; Augstein P; Northemann W; Powers AC; Ziegler M
    Acta Diabetol; 1996 Sep; 33(3):225-31. PubMed ID: 8904930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic changes of GAD65 autoantibody epitope specificities in individuals at risk of developing type 1 diabetes.
    Schlosser M; Banga JP; Madec AM; Binder KA; Strebelow M; Rjasanowski I; Wassmuth R; Gilliam LK; Luo D; Hampe CS
    Diabetologia; 2005 May; 48(5):922-30. PubMed ID: 15834701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and characterization of human monoclonal autoantibodies to glutamic acid decarboxylase.
    Hayakawa N; Premawardhana LD; Powell M; Masuda M; Arnold C; Sanders J; Evans M; Chen S; Jaume JC; Baekkeskov S; Smith BR; Furmaniak J
    Autoimmunity; 2002 Aug; 35(5):343-55. PubMed ID: 12515289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibody recognition of COOH-terminal epitopes of GAD65 marks the risk for insulin requirement in adult-onset diabetes mellitus.
    Falorni A; Gambelunghe G; Forini F; Kassi G; Cosentino A; Candeloro P; Bolli GB; Brunetti P; Calcinaro F
    J Clin Endocrinol Metab; 2000 Jan; 85(1):309-16. PubMed ID: 10634404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epitope-restricted 65-kilodalton glutamic acid decarboxylase autoantibodies among new-onset Sardinian type 2 diabetes patients define phenotypes of autoimmune diabetes.
    Maioli M; Alejandro E; Tonolo G; Gilliam LK; Bekris L; Hampe CS; Obinu DA; Manconi A; Puddu L; Lynch K; Lernmark A;
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5675-82. PubMed ID: 15531528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies to N-terminally truncated GAD improve clinical phenotyping of individuals with adult-onset diabetes: Action LADA 12.
    Achenbach P; Hawa MI; Krause S; Lampasona V; Jerram ST; Williams AJK; Bonifacio E; Ziegler AG; Leslie RD;
    Diabetologia; 2018 Jul; 61(7):1644-1649. PubMed ID: 29619531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stable GAD65 autoantibody epitope patterns in type 1 diabetes children five years after onset.
    Hampe CS; Hammerle LP; Bekris L; Ortqvist E; Persson B; Lernmark A
    J Autoimmun; 2002 Feb; 18(1):49-53. PubMed ID: 11869046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational epitopes on the diabetes autoantigen GAD65 identified by peptide phage display and molecular modeling.
    Myers MA; Davies JM; Tong JC; Whisstock J; Scealy M; Mackay IR; Rowley MJ
    J Immunol; 2000 Oct; 165(7):3830-8. PubMed ID: 11034389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.